Tuesday, May 19, 2020 9:10:47 AM
19/05/20, 8:00 AM
BEIJING, May 19, 2020 (GLOBE NEWSWIRE) -- Luckin Coffee Inc. (the “Company”) (NASDAQ: LK) today announced that on May 15, 2020, it received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Listing Qualifications Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Listing Qualifications Staff has determined to delist the Company’s securities from Nasdaq. The Listing Qualifications Staff cited two bases for the delisting determination: (i) public interest concerns as raised by the fabricated transactions disclosed by the Company in a Form 6-K on April 2, 2020, pursuant to Nasdaq Listing Rule 5101; and (ii) the Company’s past failure to publicly disclose material information, citing a business model through which the previously disclosed fabricated transactions were executed, pursuant to Nasdaq Listing Rule 5250.
The Company plans to timely request a hearing (the “Hearing”) before a Nasdaq Hearings Panel (the “Panel”). The Company will remain listed on Nasdaq, pending the outcome of the Hearing. There can be no assurance that the Panel will grant the Company’s request for continued listing. According to the Notice, the Hearing will typically be scheduled to occur approximately 30 to 45 days after the date of the hearing request.
Recent LKNCY News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 11:24:18 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 11:34:36 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/23/2024 12:00:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 04:40:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/16/2023 11:30:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/13/2023 11:35:51 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/10/2023 02:28:13 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/03/2023 09:09:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/01/2023 11:00:04 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/07/2023 02:31:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/05/2023 11:35:22 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/03/2023 11:09:52 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/03/2023 11:03:46 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/01/2023 11:00:26 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM